glp 1 receptor agonists contraindications Incretins: How we got here, where we're at and what is coming next Glucagon-like peptide-1 receptor agonists and

However, cardiovascular outcome trials (CVOTs) have not demonstrated a synergistic or additive protective effect of combined therapy on MACE or renal endpoints

For patients with advanced metabolic dysfunction, fatty liver disease, or those seeking maximal weight loss, retatrutide may become the gold standard therapy offering results previously only attainable through surgery

( 10.1172/JCI7456) [DOI] [PMC free article] [PubMed] [Google Scholar] Nikolaidis LA Elahi D Hentosz T Doverspike A Huerbin R Zourelias L Stolarski C Shen YT & Shannon RP

doi: 10.1093/humrep/dey256 2 ChangSDunaifA

Severe, persistent upper abdominal pain radiating to the back, worsening after eating, accompanied by nausea, vomiting, and fever are key warning signs requiring immediate medication discontinuation and emergency evaluation

The gut microbiota influences skeletal muscle mass and function in mice